All Episodes

May 29, 2023 68 mins

Welcome to PsychEd - the psychiatry podcast for medical learners, by medical learners. This episode covers the relationship between cannabis and psychotic disorders, as well as the potential impact of cannabis legalization in Canada, with our special guest Dr. Nitin Chopra. This episode was originated by Dr. Luke Fraccaro for his Grand Rounds.

 

The learning objectives for this episode are as follows:

 By the end of this episode, you should be able to…

  1. Briefly summarize the effects of cannabis on mental health and cognition, with a focus on psychosis.

  2. Appreciate the evidence for cannabis use as a potential cause of persistent psychotic disorders.

  3. Discuss the possible impact that recent cannabis legislation may have had on cannabis use and psychosis in Canada.

 

Guest Expert Dr. Nitin Chopra is an addictions psychiatrist at the Centre for Addiction and Mental Health (CAMH) and is an Assistant Professor in the Department of Psychiatry at the University of Toronto. He has an interest in concurrent disorders and is a staff psychiatrist on the Concurrent Addictions Inpatient Treatment Service and Concurrent Outpatient Medical and Psychosocial Addiction Support Service. Through his work on the Psychiatry Addictions Capacity Building and Consultation Service (PACCS) at CAMH and the Addiction Medicine and Psychosocial Addictions ECHO program, he is evolving into a leader in capacity building and education for addictions treatment. Furthermore, Dr. Chopra also works on the Early Psychosis Unit at CAMH and has extensive clinical experience working with patients experiencing psychosis, often with comorbid cannabis and other substance use. 

 

Grand Rounds Presenter: Dr. Luke Fraccaro (PGY3)

 

Produced by: Dr. Luke Fraccaro (PGY3), Dr. Alex Raben (staff psychiatrist), and Josh Benchaya (MS4)

 

Hosts: Dr. Luke Fraccaro (PGY3), Dr. Alex Raben (staff psychiatrist), and Josh Benchaya (MS4)

 

Audio Editing by: Dr. Luke Fraccaro (PGY3)

 

Show notes by: Dr. Luke Fraccaro (PGY3)

 

Conflicts of Interest: There are no known conflict of interests to report

 

Topics:

  • 0:00 - Introduction

  • 2:50 - Objectives

  • 3:55 - Case example

  • 7:25 - Overview of cannabis effects of mental health

  • 10:45 - Differentiating clinically between cannabis-induced psychosis and a primary psychotic disorder

  • 13:11 - Cannabis causing acute psychotic symptoms

  • 14:15 - Back to the case

  • 16:05 - Overlapping risk factors for cannabis use and psychotic disorders

  • 18:14 - Cannabis use as a potential cause of persistent psychotic disorders (Reviewing the evidence)

  • 30:14 - Summary of the relationship between cannabis and psychosis and how to apply it clinically

  • 35:20 - Cannabis legalization in Canada

  • 39:45 - Canadian studies on potential impact of cannabis legalization on psychosis

  • 44:33 - Brief review of American studies on potential impact of cannabis legalization on psychosis.

  • 46:35 - Summary of potential impact of legalization

  • 47:42 - Questions and discussion

  • 1:06:15 - Summary and Outro

 

Resources:

  • Canada

Mark as Played

Advertise With Us

Popular Podcasts

Dateline NBC

Dateline NBC

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com

24/7 News: The Latest

24/7 News: The Latest

The latest news in 4 minutes updated every hour, every day.

Therapy Gecko

Therapy Gecko

An unlicensed lizard psychologist travels the universe talking to strangers about absolutely nothing. TO CALL THE GECKO: follow me on https://www.twitch.tv/lyleforever to get a notification for when I am taking calls. I am usually live Mondays, Wednesdays, and Fridays but lately a lot of other times too. I am a gecko.

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2025 iHeartMedia, Inc.